Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ATEC Alphatec	$16.03 -0.9%	$12.78	$4.88 ▼ $16.47	$2.39B	1.05	3.26 million shs	3.59 million shs
GMED Globus Medical	$61.16 -0.6%	$57.58	$51.79 ▼ $94.93	$8.31B	1.2	1.43 million shs	759,848 shs
MASI Masimo	$140.95 -1.1%	$157.68	$107.98 ▼ $194.88	$7.74B	1.21	888,083 shs	668,122 shs
TFX Teleflex	$126.28 -2.5%	$118.88	$108.90 ▼ $249.90	$5.72B	1.08	586,802 shs	436,361 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ATEC Alphatec	-0.93%	+0.63%	+47.33%	+29.07%	+156.48%
GMED Globus Medical	-0.63%	+1.09%	+13.13%	+3.34%	-14.31%
MASI Masimo	-1.08%	-2.28%	-11.32%	-12.65%	+21.11%
TFX Teleflex	-2.43%	+1.41%	+9.13%	+3.35%	-47.80%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ATEC Alphatec	4.0021 of 5 stars	2.5	2.0	0.0	3.3	3.5	4.2	0.6
GMED Globus Medical	4.9592 of 5 stars	4.3	3.0	0.0	4.1	3.1	2.5	3.1
MASI Masimo	4.4168 of 5 stars	3.4	1.0	0.0	4.2	3.2	3.3	1.3
TFX Teleflex	4.7464 of 5 stars	2.0	5.0	2.5	3.9	2.9	3.3	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ATEC Alphatec	3.00	Buy	$18.50	15.41% Upside
GMED Globus Medical	2.62	Moderate Buy	$87.64	43.30% Upside
MASI Masimo	2.83	Moderate Buy	$193.60	37.35% Upside
TFX Teleflex	2.00	Hold	$141.57	12.11% Upside

Current Analyst Ratings Breakdown

Latest ATEC, MASI, GMED, and TFX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/14/2025	MASI Masimo	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/8/2025	GMED Globus Medical	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$76.00 ➝ $66.00
8/6/2025	MASI Masimo	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$200.00 ➝ $210.00
8/4/2025	ATEC Alphatec	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$21.00 ➝ $22.00
8/1/2025	ATEC Alphatec	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$20.00
8/1/2025	TFX Teleflex	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$130.00 ➝ $135.00
8/1/2025	TFX Teleflex	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$130.00 ➝ $135.00
8/1/2025	TFX Teleflex	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$137.00 ➝ $131.00
7/22/2025	GMED Globus Medical	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$97.00 ➝ $90.00
7/21/2025	GMED Globus Medical	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
7/16/2025	TFX Teleflex	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$150.00 ➝ $130.00

(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ATEC Alphatec	$611.56M	3.88	N/A	N/A	$0.16 per share	100.19
GMED Globus Medical	$2.52B	3.28	$6.62 per share	9.24	$31.81 per share	1.92
MASI Masimo	$2.09B	3.66	$6.32 per share	22.31	$19.20 per share	7.34
TFX Teleflex	$3.05B	1.83	$24.71 per share	5.11	$96.01 per share	1.32

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ATEC Alphatec	-$162.12M	-$1.13	N/A	N/A	N/A	-24.33%	-1,657.19%	-21.44%	10/29/2025 (Estimated)
GMED Globus Medical	$102.98M	$2.60	23.52	15.18	1.72	13.58%	10.65%	8.86%	11/4/2025 (Estimated)
MASI Masimo	-$304.90M	-$8.52	N/A	30.44	N/A	-24.85%	26.54%	11.49%	11/4/2025 (Estimated)
TFX Teleflex	$69.68M	$4.25	29.71	8.32	1.81	6.31%	15.08%	8.85%	10/30/2025 (Estimated)

Latest ATEC, MASI, GMED, and TFX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	GMED Globus Medical	$0.76	$0.86	+$0.10	$1.50	$738.91 million	$745.34 million
8/5/2025	Q2 2025	MASI Masimo	$1.22	$1.33	+$0.11	$0.94	$368.65 million	$370.90 million
7/31/2025	Q2 2025	ATEC Alphatec	-$0.06	$0.02	+$0.08	-$0.27	$178.85 million	$185.54 million
7/31/2025	Q2 2025	TFX Teleflex	$3.36	$3.73	+$0.37	$2.77	$771.53 million	$780.90 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ATEC Alphatec	N/A	N/A	N/A	N/A	N/A
GMED Globus Medical	N/A	N/A	N/A	N/A	N/A
MASI Masimo	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.08%	N/A	32.00%	N/A

Latest ATEC, MASI, GMED, and TFX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/31/2025	TFX Teleflex	quarterly	$0.34	1.19%	8/15/2025	8/15/2025	9/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ATEC Alphatec	23.22	2.88	1.77
GMED Globus Medical	N/A	4.07	2.26
MASI Masimo	0.57	2.14	1.61
TFX Teleflex	0.42	2.41	1.44

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ATEC Alphatec	66.35%
GMED Globus Medical	95.16%
MASI Masimo	85.96%
TFX Teleflex	95.62%

Insider Ownership

Company	Insider Ownership
ATEC Alphatec	20.90%
GMED Globus Medical	18.51%
MASI Masimo	9.70%
TFX Teleflex	1.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ATEC Alphatec	700	147.98 million	117.06 million	Optionable
GMED Globus Medical	5,300	135.06 million	110.06 million	Optionable
MASI Masimo	5,600	54.33 million	49.06 million	Optionable
TFX Teleflex	14,100	44.19 million	43.57 million	Optionable

ATEC, MASI, GMED, and TFX Headlines

Recent News About These Companies

APG Asset Management N.V. Sells 3,602 Shares of Teleflex Incorporated $TFX

1 hour ago | marketbeat.com

Are Investors Undervaluing Teleflex (TFX) Right Now?

August 28 at 10:40 AM | zacks.com

FORA Capital LLC Invests $4.82 Million in Teleflex Incorporated $TFX

August 28 at 7:54 AM | marketbeat.com

Walleye Capital LLC Raises Position in Teleflex Incorporated $TFX

August 28 at 6:38 AM | marketbeat.com

Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

August 26 at 6:30 AM | globenewswire.com

Bahl & Gaynor Inc. Has $2.06 Million Holdings in Teleflex Incorporated $TFX

August 26 at 6:09 AM | marketbeat.com

Capital Fund Management S.A. Buys New Position in Teleflex Incorporated $TFX

August 25, 2025 | marketbeat.com

Dimensional Fund Advisors LP Grows Stake in Teleflex Incorporated $TFX

August 25, 2025 | marketbeat.com

Invesco Ltd. Sells 934,736 Shares of Teleflex Incorporated $TFX

August 24, 2025 | marketbeat.com

115,163 Shares in Teleflex Incorporated $TFX Acquired by Nuveen LLC

August 23, 2025 | marketbeat.com

TFX or SONVY: Which Is the Better Value Stock Right Now?

August 22, 2025 | zacks.com

T. Rowe Price Investment Management Inc. Raises Stake in Teleflex Incorporated $TFX

August 22, 2025 | marketbeat.com

Algert Global LLC Buys New Holdings in Teleflex Incorporated $TFX

August 22, 2025 | marketbeat.com

Teleflex Stock Gains Following Barrigel's Launch in Japan

August 21, 2025 | zacks.com

What Teleflex (TFX)'s Barrigel Launch in Japan Means for Shareholders

August 21, 2025 | finance.yahoo.com

Kovitz Investment Group Partners LLC Invests $2.16 Million in Teleflex Incorporated $TFX

August 21, 2025 | marketbeat.com

Teleflex Incorporated $TFX Shares Sold by Russell Investments Group Ltd.

August 21, 2025 | marketbeat.com

1 Healthcare Stock Worth Investigating and 2 Facing Challenges

August 20, 2025 | finance.yahoo.com

4 PEG-Based Value Stocks That Could Help You Crush the Market

August 20, 2025 | zacks.com

Quantbot Technologies LP Increases Stock Position in Teleflex Incorporated $TFX

August 20, 2025 | marketbeat.com

Teleflex Incorporated $TFX Stake Trimmed by Fjarde AP Fonden Fourth Swedish National Pension Fund

August 20, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ATEC, MASI, GMED, and TFX Company Descriptions

Alphatec NASDAQ:ATEC

$16.03 -0.15 (-0.93%)

Closing price 08/28/2025 04:00 PM Eastern

Extended Trading

$15.69 -0.34 (-2.12%)

As of 08/28/2025 05:50 PM Eastern

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Globus Medical NYSE:GMED

$61.16 -0.35 (-0.57%)

Closing price 08/28/2025 03:59 PM Eastern

Extended Trading

$61.05 -0.11 (-0.18%)

As of 05:25 AM Eastern

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Masimo NASDAQ:MASI

$140.95 -1.54 (-1.08%)

Closing price 08/28/2025 04:00 PM Eastern

Extended Trading

$139.50 -1.45 (-1.03%)

As of 05:34 AM Eastern

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Teleflex NYSE:TFX

$126.28 -3.22 (-2.49%)

Closing price 08/28/2025 03:59 PM Eastern

Extended Trading

$125.25 -1.03 (-0.82%)

As of 05:26 AM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time